#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    ROHHAD syndrome Li-Fraumeni syndrome Epstein-Barr virus infection Becker's muscular dystrophy Fibrous dysplasia of bone Plasma cell myeloma recurrent Short stature homeobox gene mutation Extranodal marginal zone B-cell lymphoma (MALT type) Cholangiosarcoma Biotinidase deficiency Anal fistula ABO haemolytic disease of newborn Burkitt's lymphoma Cognitive disorder Neuroendocrine cell hyperplasia of infancy More trials…

    Learn about Rare Diseases

    Nephrotic syndrome – Basic Information Ewing’s sarcoma Alexander disease – Trials in Disease Haemophilia A with anti factor VIII – Basic Information Metachromatic leukodystrophy – Treatment Sjogren’s syndrome – Trials in Disease Glomerulonephritis rapidly progressive – Basic Information Short-bowel syndrome Haemophilia B with anti factor IX – Treatment VEXAS syndrome – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Midomafetamine Hydrochloride LUNRESERTIB Regn7508 Elebsiran Nortriptyline Hydrochloride Gozetotide Glycopyrronium Bromide TEV-53408 Hydroxi-Methionine Calcium Cart45Ra-Nkg2D Cells Ropivacaine Bms-986408 Remifentanil Folinic Acid SKB410 Tiragolumab Azd3427 Briquilimab Brentuximab Vedotin LIPASE More therapies…

    Learn about Your Condition

    Cardiac arrest Tubulointerstitial nephritis Amnestic disorder Lichenoid keratosis Meniere's disease Spondylolisthesis Perinatal depression Tumour thrombosis Petit mal epilepsy Pathogen resistance Glioblastoma Anogenital dysplasia Ulcerative keratitis Langerhans' cell histiocytosis Hypoparathyroidism More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • A study to evaluate the safety of MK-1403 in healthy men for the treatment of atherosclerosis

    Not recruiting

    1 1
    Investigated Diseases:
    • Arteriosclerosis
    Belgium

  • A study comparing the absorption of rosuvastatin, amlodipine, and ramipril in healthy men and women.

    Not recruiting

    1 1 1 1
    Investigated Diseases:
    • Hypertension
    Investigated Drugs:
    • Amlodipine Besilate
    • Ramipril
    • Amlodipine
    Czechia

  • Bioequivalence study of ezetimibe and atorvastatin tablets versus film‑coated tablets in healthy volunteers

    Not recruiting

    1 1 1 1
    Investigated Drugs:
    • Atorvastatin Calcium
    • Ezetimibe
    • Atorvastatin
    Spain

  • A study of the effects of AGMB-129 and midazolam in healthy participants

    Not recruiting

    1 1 1 1
    Investigated Diseases:
    • Crohn’s disease
    Investigated Drugs:
    • ORG-129
    • Midazolam
    Belgium

  • A study to evaluate how JNJ-77242113 is absorbed by the body in healthy participants for the treatment of inflammatory diseases.

    Not recruiting

    1 1 1
    Investigated Diseases:
    • Inflammation
    Belgium

  • Study to evaluate the effects of brexanolone and lorazepam on the nervous system in healthy male participants using magnetic brain stimulation

    Not recruiting

    1 1 1
    Investigated Drugs:
    • Lorazepam
    The Netherlands
Previous Page
1 … 923 924 925 926 927 … 1,675
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!